Cargando…

Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models

BACKGROUND: Patients taking medication with high anticholinergic and sedative properties are at increased risk of experiencing poor cognitive and physical outcomes. Therefore, precise quantification of the cumulative burden of their drug regimen is advisable. There is no agreement regarding which sc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al Rihani, Sweilem B., Deodhar, Malavika, Darakjian, Lucy I., Dow, Pamela, Smith, Matt K., Bikmetov, Ravil, Turgeon, Jacques, Michaud, Veronique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592980/ https://www.ncbi.nlm.nih.gov/pubmed/34751922 http://dx.doi.org/10.1007/s40266-021-00895-x

Ejemplares similares

Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy
por: Al Rihani, Sweilem B., et al.
Publicado: (2020)

Adverse drug event risk assessment by the virtual addition of COVID‐19 repurposed drugs to Medicare and commercially insured patients’ drug regimens: A drug safety simulation study
por: Smith, Matt K., et al.
Publicado: (2021)

Disease-Induced Modulation of Drug Transporters at the Blood–Brain Barrier Level
por: Al Rihani, Sweilem B., et al.
Publicado: (2021)

Assessing the Mechanism of Fluoxetine-Mediated CYP2D6 Inhibition
por: Deodhar, Malavika, et al.
Publicado: (2021)

Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice
por: Deodhar, Malavika, et al.
Publicado: (2020)

Use of Drug Claims Data and a Medication Risk Score to Assess the Impact of CYP2D6 Drug Interactions among Opioid Users on Healthcare Costs
por: Michaud, Veronique, et al.
Publicado: (2021)

ACE2 as a Therapeutic Target for COVID-19; Its Role in Infectious Processes and Regulation by Modulators of the RAAS System
por: Michaud, Veronique, et al.
Publicado: (2020)

Risk Assessment of Drug‐Induced Long QT Syndrome for Some COVID‐19 Repurposed Drugs
por: Michaud, Veronique, et al.
Publicado: (2020)

Chronic Inflammatory Status Observed in Patients with Type 2 Diabetes Induces Modulation of Cytochrome P450 Expression and Activity
por: Darakjian, Lucy, et al.
Publicado: (2021)

The evaluation of relationship between polypharmacy and anticholinergic burden scales
por: Okudur, Saadet Koc, et al.
Publicado: (2021)

Automated Detection of Patients at High Risk of Polypharmacy including Anticholinergic and Sedative Medications
por: Shirazibeheshti, Amirali, et al.
Publicado: (2023)

Classification and Assessment of Medication Risk in the Elderly (CARE): Use of a Medication Risk Score to Inform Patients’ Readmission Likelihood after Hospital Discharge
por: SanFilippo, Savanna, et al.
Publicado: (2021)

Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism
por: Deodhar, Malavika, et al.
Publicado: (2021)

Polypharmacy and cumulative anticholinergic burden in older adults hospitalized with fall
por: Wong, Ho Lun, et al.
Publicado: (2023)

Pharmacist‐driven interventions to de‐escalate urinary antimuscarinics in the Programs of All‐Inclusive Care for the Elderly
por: Ha, Meghan, et al.
Publicado: (2022)

Anticholinergic Burden and Fractures: A Systematic Review with Methodological Appraisal
por: Reinold, Jonas, et al.
Publicado: (2020)

Association between Anticholinergic Burden and Constipation: A Systematic Review
por: Rodríguez-Ramallo, Héctor, et al.
Publicado: (2021)

Precision Medicine: Applied Concepts of Pharmacogenomics in Patients with Various Diseases and Polypharmacy
por: Michaud, Veronique, et al.
Publicado: (2021)

Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities
por: Ailabouni, Nagham, et al.
Publicado: (2017)

Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review
por: Salahudeen, Mohammed Saji, et al.
Publicado: (2015)

Longitudinal Association of a Medication Risk Score With Mortality Among Ambulatory Patients Acquired Through Electronic Health Record Data
por: Ratigan, Amanda Rondinelli, et al.
Publicado: (2021)

Reducing the anticholinergic and sedative load in older patients on polypharmacy by pharmacist-led medication review: a randomised controlled trial
por: van der Meer, Helene G, et al.
Publicado: (2018)

Deprescribing Anticholinergic and Sedative Drugs to Reduce Polypharmacy in Frail Older Adults Living in the Community: A Randomized Controlled Trial
por: Jamieson, Hamish, et al.
Publicado: (2023)

Anticholinergic burden measures and older people’s falls risk: a systematic prognostic review
por: Stewart, Carrie, et al.
Publicado: (2021)

Interventions for reducing anticholinergic medication burden in older adults—a systematic review and meta-analysis
por: Braithwaite, Eve, et al.
Publicado: (2023)

Delirium is not associated with anticholinergic burden or polypharmacy in older patients on admission to an acute hospital: an observational case control study
por: Moorey, Hannah C., et al.
Publicado: (2016)

Anticholinergic and sedative drug burden in community-dwelling older people: a national database study
por: Byrne, Catherine J, et al.
Publicado: (2018)

Misuse of Anticholinergic Medications: A Systematic Review
por: Chiappini, Stefania, et al.
Publicado: (2022)

Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug Interactions
por: Rutman, Matthew P., et al.
Publicado: (2021)

Anticholinergic Burden, Polypharmacy, and Cognition in Parkinson's Disease Patients with Mild Cognitive Impairment: A Cross-Sectional Observational Study
por: Sumbul-Sekerci, Betul, et al.
Publicado: (2023)

Anticholinergic burden measures, symptoms, and fall-associated risk in older adults with polypharmacy: Development and validation of a prognostic model
por: Dinh, Truc Sophia, et al.
Publicado: (2023)

Anticholinergic and Sedative Drug Burden and Functional Recovery after Cerebrovascular Accident: A Retrospective Descriptive Study
por: Ogawa, Yukari, et al.
Publicado: (2020)

Evaluation of the Effect of a Safe Medication Strategy on Potentially Inappropriate Medications, Polypharmacy and Anticholinergic Burden for People with Dementia: An Intervention Study
por: Kable, Ashley, et al.
Publicado: (2023)

Quantification of anticholinergic and sedative drug load with the Drug Burden Index: a review of outcomes and methodological quality of studies
por: Wouters, Hans, et al.
Publicado: (2016)

Insights from the AQUA Registry: a retrospective study of anticholinergic polypharmacy in the United States
por: Cooperberg, Matthew R., et al.
Publicado: (2023)

Anticholinergic Burden of Geriatric Ward Inpatients
por: Wilczyński, Krzysztof, et al.
Publicado: (2021)

The anticholinergic burden: from research to practice
por: Hilmer, Sarah N, et al.
Publicado: (2022)

Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community
por: Bergler, Ulrich, et al.
Publicado: (2021)

Integration of an electronic Drug Burden Index risk assessment tool into Home Medicines Reviews: deprescribing anticholinergic and sedative medications
por: Kouladjian O’Donnell, Lisa, et al.
Publicado: (2019)

Anticholinergic Burden and Most Common Anticholinergic-acting Medicines in Older General Practice Patients
por: Gorup, Eva, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hb8op031001tgba5s6fg31rqop